Johnson & Johnson’s two-dose Ebola vaccine regimen is safe, well tolerated and produces a strong immune response
by Press Release from Outbreak News Today on (#5QFRF)
By NewsDesk @infectiousdiseasenews Johnson & Johnson's two-dose Ebola vaccine regimen is safe, well tolerated and produces a strong immune response in people over the age of one, according to two new papers published in The Lancet Infectious Diseases. The EBOVAC-Salone study provides important further evidence for the potential of the regimen using the Ad26.ZEBOV and MVA-BN-Filo vaccines to be [...]
The post Johnson & Johnson's two-dose Ebola vaccine regimen is safe, well tolerated and produces a strong immune response appeared first on Outbreak News Today.